Izrael - hebrajski - Ministry of Health

fresenius medical care israel p.b., ltd. - calcium chloride dihydrate; glucose monohydrate; magnesium chloride hexahydrate; sodium (s) - lactate; sodium chloride - תמיסה לדיאליזה פריטוניאלית - sodium (s) - lactate 3.925 g / 1 l; glucose monohydrate 25 g / 1 l; magnesium chloride hexahydrate 0.1017 g / 1 l; calcium chloride dihydrate 0.1838 g / 1 l; sodium chloride 5.640 g / 1 l - sodium chloride

Izrael - hebrajski - Ministry of Health

fresenius medical care israel p.b., ltd. - calcium chloride dihydrate; glucose monohydrate; magnesium chloride hexahydrate; sodium (s) - lactate; sodium chloride - תמיסה לדיאליזה פריטוניאלית - sodium (s) - lactate 3.925 g / 1 l; glucose monohydrate 16.50 g / 1 l; magnesium chloride hexahydrate 0.1017 g / 1 l; calcium chloride dihydrate 0.2573 g / 1 l; sodium chloride 5.640 g / 1 l - sodium chloride

Izrael - hebrajski - Ministry of Health

fresenius medical care israel p.b., ltd. - calcium chloride dihydrate; glucose monohydrate; magnesium chloride hexahydrate; sodium (s) - lactate; sodium chloride - תמיסה לדיאליזה פריטוניאלית - sodium (s) - lactate 3.925 g / 1 l; glucose monohydrate 25 g / 1 l; magnesium chloride hexahydrate 0.1017 g / 1 l; calcium chloride dihydrate 0.2573 g / 1 l; sodium chloride 5.640 g / 1 l - sodium chloride

Izrael - hebrajski - Ministry of Health

fresenius medical care israel p.b., ltd. - calcium chloride dihydrate; glucose monohydrate; magnesium chloride hexahydrate; sodium (s) - lactate; sodium chloride - תמיסה לדיאליזה פריטוניאלית - sodium (s) - lactate 3.925 g / 1 l; glucose monohydrate 46.75 g / 1 l; magnesium chloride hexahydrate 0.1017 g / 1 l; calcium chloride dihydrate 0.1838 g / 1 l; sodium chloride 5.640 g / 1 l - sodium chloride

Izrael - hebrajski - Ministry of Health

fresenius medical care israel p.b., ltd. - calcium chloride dihydrate; glucose monohydrate; magnesium chloride hexahydrate; sodium (s) - lactate; sodium chloride - תמיסה לדיאליזה פריטוניאלית - sodium (s) - lactate 3.925 g / 1 l; glucose monohydrate 46.75 g / 1 l; magnesium chloride hexahydrate 0.1017 g / 1 l; calcium chloride dihydrate 0.2573 g / 1 l; sodium chloride 5.640 g / 1 l - sodium chloride

Izrael - hebrajski - Ministry of Health

novartis pharma services ag - tetracosactide hexaacetate 1 mg/ml - suspension for injection - tetracosactide - collagen diseases, neurological diseases, chronic skin disorders.

Izrael - hebrajski - Ministry of Health

pfizer pharmaceuticals israel ltd - axitinib - טבליות מצופות פילם - axitinib 1 mg - axitinib - axitinib - for the treatment of advanced renal cell carcinoma (rcc) after failure of one prior systemic therapy.

Izrael - hebrajski - Ministry of Health

pfizer pharmaceuticals israel ltd - axitinib - טבליות מצופות פילם - axitinib 5 mg - axitinib - axitinib - for the treatment of advanced renal cell carcinoma (rcc) after failure of one prior systemic therapy.

Izrael - hebrajski - Ministry of Health

alexion pharma israel ltd - eculizumab - תרכיז להכנת תמיסה לאינפוזיה - eculizumab 10 mg/ml - eculizumab - eculizumab - soliris is indicated for the treatment of patients with: - paroxysmal nocturnal hemoglobinuria ( pnh ).- atypical hemolytic uremic syndrome (ahus).

Izrael - hebrajski - Ministry of Health

teva pharmaceutical industries ltd, israel - ramipril - טבליה - ramipril 5 mg - ramipril - ramipril - - hypertension - congestive heart failure - reduction of mortality in patients after mi with left ventricular dysfunction for reducing the risk of myocardial infarction stoke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous mi unstable angina or multivessel cabg or multivessel ptca) stroke or peripheral vascular disease. also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmhg or diastolic pressure > 90 mmhg) high total cholesterol (>5.2 mmol/l) low hdl ( <0.9 mmol/l) current smoker known microalbuminuria clinical evidence of previous vascular disease. - prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.